FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308187722> ?p ?o ?g. }

• W4308187722 endingPage "153303382211329" @default.
• W4308187722 startingPage "153303382211329" @default.
• W4308187722 abstract "Background: Palbociclib is the most widely used cyclin-dependent kinase 4/6 inhibitor in China, but its early application efficacy on Chinese metastatic breast cancer (MBC) patients was reported deficiently. Methods: Between February 2019 to December 2021, 95 female hormone receptor-positive (HR+)/human epidermal growth factor receptor-2 negative (HER2−) patients with MBC received palbociclib combined with AI or fulvestrant were retrospectively analyzed in our center. The primary outcome was progression-free survival (PFS). The objective response rate and clinical benefit rate (CBR) were evaluated. Results: The median follow-up period was 15 months (range from 2 to 37). Palbociclib performed superiorly when applicated in first-and-second line therapy than in later lines ( P = .002). Palbociclib combined with AI or fulvestrant had a median PFS of 34 months (95% confidence interval [CI] = 6.87-61.13) and 12 months (95%CI = 7.76-16.24), respectively. Univariate subgroup analysis showed that the previous history of salvage chemotherapy ( P = .015) and the presence of liver metastases ( P < .001) significantly affected the efficacy of palbociclib. Despite the existence of liver metastases and primary endocrine resistance, which are two independent predictors of poor prognosis, early application of palbociclib in advanced stage can bring further benefits to these two groups of patients, rather than choosing salvage chemotherapy in the first place. Conclusion: Palbociclib combined with endocrine therapy has a favorable efficacy and acceptable toxicity in HR+/HER2− Chinese MBC patients. Better performance can be seen when palbociclib was applicated in the early stage." @default.
• W4308187722 created "2022-11-09" @default.
• W4308187722 creator A5006213041 @default.
• W4308187722 creator A5012018493 @default.
• W4308187722 creator A5066193828 @default.
• W4308187722 creator A5070082606 @default.
• W4308187722 creator A5082684065 @default.
• W4308187722 date "2022-01-01" @default.
• W4308187722 modified "2023-09-26" @default.
• W4308187722 title "Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population" @default.
• W4308187722 cites W2016538479 @default.
• W4308187722 cites W2059796825 @default.
• W4308187722 cites W2083296039 @default.
• W4308187722 cites W2114853122 @default.
• W4308187722 cites W2116760308 @default.
• W4308187722 cites W2159427817 @default.
• W4308187722 cites W2255638054 @default.
• W4308187722 cites W2560635244 @default.
• W4308187722 cites W2620993107 @default.
• W4308187722 cites W2804105316 @default.
• W4308187722 cites W2898684787 @default.
• W4308187722 cites W2912993657 @default.
• W4308187722 cites W2943438364 @default.
• W4308187722 cites W2945884415 @default.
• W4308187722 cites W2969690362 @default.
• W4308187722 cites W2982150569 @default.
• W4308187722 cites W2995593755 @default.
• W4308187722 cites W3096462237 @default.
• W4308187722 cites W3109881382 @default.
• W4308187722 cites W3121771782 @default.
• W4308187722 cites W3158094837 @default.
• W4308187722 cites W3165174637 @default.
• W4308187722 cites W3165252948 @default.
• W4308187722 cites W3202860822 @default.
• W4308187722 cites W3207439319 @default.
• W4308187722 cites W3216407617 @default.
• W4308187722 cites W4200136212 @default.
• W4308187722 cites W4206666777 @default.
• W4308187722 cites W4214887509 @default.
• W4308187722 cites W4224239651 @default.
• W4308187722 cites W4224717515 @default.
• W4308187722 cites W4234050115 @default.
• W4308187722 doi "https://doi.org/10.1177/15330338221132926" @default.
• W4308187722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36310472" @default.
• W4308187722 hasPublicationYear "2022" @default.
• W4308187722 type Work @default.
• W4308187722 citedByCount "0" @default.
• W4308187722 crossrefType "journal-article" @default.
• W4308187722 hasAuthorship W4308187722A5006213041 @default.
• W4308187722 hasAuthorship W4308187722A5012018493 @default.
• W4308187722 hasAuthorship W4308187722A5066193828 @default.
• W4308187722 hasAuthorship W4308187722A5070082606 @default.
• W4308187722 hasAuthorship W4308187722A5082684065 @default.
• W4308187722 hasBestOaLocation W43081877221 @default.
• W4308187722 hasConcept C121608353 @default.
• W4308187722 hasConcept C126322002 @default.
• W4308187722 hasConcept C143998085 @default.
• W4308187722 hasConcept C2775930923 @default.
• W4308187722 hasConcept C2776694085 @default.
• W4308187722 hasConcept C2779744173 @default.
• W4308187722 hasConcept C2780482068 @default.
• W4308187722 hasConcept C2908647359 @default.
• W4308187722 hasConcept C29456083 @default.
• W4308187722 hasConcept C530470458 @default.
• W4308187722 hasConcept C71924100 @default.
• W4308187722 hasConcept C84606932 @default.
• W4308187722 hasConcept C99454951 @default.
• W4308187722 hasConceptScore W4308187722C121608353 @default.
• W4308187722 hasConceptScore W4308187722C126322002 @default.
• W4308187722 hasConceptScore W4308187722C143998085 @default.
• W4308187722 hasConceptScore W4308187722C2775930923 @default.
• W4308187722 hasConceptScore W4308187722C2776694085 @default.
• W4308187722 hasConceptScore W4308187722C2779744173 @default.
• W4308187722 hasConceptScore W4308187722C2780482068 @default.
• W4308187722 hasConceptScore W4308187722C2908647359 @default.
• W4308187722 hasConceptScore W4308187722C29456083 @default.
• W4308187722 hasConceptScore W4308187722C530470458 @default.
• W4308187722 hasConceptScore W4308187722C71924100 @default.
• W4308187722 hasConceptScore W4308187722C84606932 @default.
• W4308187722 hasConceptScore W4308187722C99454951 @default.
• W4308187722 hasLocation W43081877221 @default.
• W4308187722 hasLocation W43081877222 @default.
• W4308187722 hasLocation W43081877223 @default.
• W4308187722 hasOpenAccess W4308187722 @default.
• W4308187722 hasPrimaryLocation W43081877221 @default.
• W4308187722 hasRelatedWork W2292433415 @default.
• W4308187722 hasRelatedWork W2740803632 @default.
• W4308187722 hasRelatedWork W2751810360 @default.
• W4308187722 hasRelatedWork W2762467781 @default.
• W4308187722 hasRelatedWork W2892008472 @default.
• W4308187722 hasRelatedWork W3093743109 @default.
• W4308187722 hasRelatedWork W3161515104 @default.
• W4308187722 hasRelatedWork W3203690439 @default.
• W4308187722 hasRelatedWork W4226356606 @default.
• W4308187722 hasRelatedWork W4282924254 @default.
• W4308187722 hasVolume "21" @default.
• W4308187722 isParatext "false" @default.
• W4308187722 isRetracted "false" @default.

• next